The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane
Open accessAbstract
An activity that is inhibitory to the properdin-stabilized amplification C3 convertase (C3b,Bb,P) was solubilized from human erythrocyte (E hu ) membranes by Nonidet P-40 and purified to homogeneity. The inhibitory membrane glycoprotein had an apparent M r of 1-1.2×10 6 on gel filtration in the presence of Nonidet P-40. On sodium dodecyl sulfate/polyacrylamide gel electrophoresis it presented a single stained band with an apparent M r of 205,000, with or without prior reduction of disulfides. The inhibitory protein of the E hu membrane produced a dose-related, first-order decay of C3b,Bb,P function on sheep erythrocytes (E s ) and released 125 I-labeled Bb from these sites, indicating a mechanism of inhibition by decay-dissociation of the amplification C3 convertase. The 50% inhibitory dose of the E hu membrane protein was not altered by removal of sialic acid from the E s bearing C3b,Bb,P sites. E hu membrane protein also serves as a cofactor for C3b inactivator-induced cleavage of the α polypeptide chain of C3b. Thus, the inhibitory membrane protein can abrogate the activity of amplification convertase sites that have formed and also can prevent generation of such sites by augmenting irreversible inactivation of C3b. Discrimination between cells by the alternative complement pathway occurs after initial deposition of C3b and is related to the modulation by surface constituents of the capacity of bound C3b to function as a subunit of the amplification C3 convertase. The existence in the E hu membrane of a protein that can impair the functions of membrane-bound C3b and C3b,Bb,P could represent a molecular basis for preventing inappropriate self-recognition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Weber, K., & Osborn, M. (1969) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)94333-4 · Cited by 20,298
Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane
Fairbanks, G., Steck, T. L., & Wallach, D. F. H. (1971) · Biochemistry · doi:10.1021/bi00789a030 · Cited by 8,526
The Thiobarbituric Acid Assay of Sialic Acids
Warren, L. (1959) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)69851-5 · Cited by 6,433
Chemical Coupling of Peptides and Proteins to Polysaccharides by Means of Cyanogen Halides
AXÉN, R., PORATH, J., & ERNBACK, S. (1967) · Nature · doi:10.1038/2141302a0 · Cited by 2,159
Pangburn, M. K., Schreiber, R. D., & Müller-Eberhard, H. J. (1977) · The Journal of experimental medicine · doi:10.1084/jem.146.1.257 · Cited by 684
Modulation of the alternative complement pathways by beta 1 H globulin.
Whaley, K., & Ruddy, S. (1976) · The Journal of experimental medicine · doi:10.1084/jem.144.5.1147 · Cited by 583
Control of the amplification convertase of complement by the plasma protein beta1H.
Weiler, J. M., Daha, M. R., Austen, K. F., & Fearon, D. T. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.9.3268 · Cited by 570
Self-citationThird component of human complement: purification from plasma and physicochemical characterization
Tack, B. F., & Prahl, J. W. (1976) · Biochemistry · doi:10.1021/bi00665a028 · Cited by 516
Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase.
Fearon, D. T., & Austen, K. F. (1975) · The Journal of experimental medicine · doi:10.1084/jem.142.4.856 · Cited by 481
Self-citation
Cited by
Weisman, H. F., Bartow, T., Leppo, M. K., Marsh, H. C., Carson, G. R., Concino, M. F., Boyle, M. P., Roux, K. H., Weisfeldt, M. L., & Fearon, D. T. (1990) · Science · doi:10.1126/science.2371562 · Cited by 977
Self-citationFearon, D. (1980) · The Journal of Experimental Medicine · doi:10.1084/jem.152.1.20 · Cited by 644
Self-citationMedof, M. E., Kinoshita, T., & Nussenzweig, V (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.5.1558 · Cited by 561
Structure and Function of the Complement Receptors, CR1 (CD35) and CR2 (CD21)
Ahearn, J. M., & Fearon, D. T. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60654-9 · Cited by 448
Self-citationThe Regulators of Complement Activation (RCA) Gene Cluster
Hourcade, D., Holers, V. M., & Atkinson, J. P. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60697-5 · Cited by 439
Nicholson-Weller, A., March, J. P., Rosenfeld, S. I., & Austen, K. F. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.16.5066 · Cited by 428
Molecular Biology and Chemistry of the Alternative Pathway of Complement
Müller-Eberhard, H. J., & Schreiber, R. D. (1980) · Advances in Immunology · doi:10.1016/s0065-2776(08)60042-5 · Cited by 408
Fishelson, Z. (2003) · Molecular Immunology · doi:10.1016/s0161-5890(03)00112-3 · Cited by 400
Seya, T., Turner, J. R., & Atkinson, J. P. (1986) · The Journal of experimental medicine · doi:10.1084/jem.163.4.837 · Cited by 398
Friedman, H. M., Cohen, G. H., Eisenberg, R. J., Seidel, C. A., & Cines, D. B. (1984) · Nature · doi:10.1038/309633a0 · Cited by 383
Risitano, A. M., Notaro, R., Marando, L., Serio, B., Ranaldi, D., Seneca, E., Ricci, P., Alfinito, F., Camera, A., Gianfaldoni, G., et al. (2009) · Blood · doi:10.1182/blood-2008-11-189944 · Cited by 361
Pharmacology of the Eosinophil
Giembycz, M. A., & Lindsay, M. A. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01404-2 · Cited by 351
Iida, K., Mornaghi, R., & Nussenzweig, V (1982) · The Journal of experimental medicine · doi:10.1084/jem.155.5.1427 · Cited by 339
Medof, M. E., Iida, K., Mold, C., & Nussenzweig, V (1982) · The Journal of experimental medicine · doi:10.1084/jem.156.6.1739 · Cited by 334
Pangburn, M. K., Schreiber, R. D., & Müller-Eberhard, H. J. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.17.5430 · Cited by 317
Membrane Complement Receptors Specific for Bound Fragments of C3
Ross, G. D., & Medof, M. E. (1985) · Advances in Immunology · doi:10.1016/s0065-2776(08)60341-7 · Cited by 308
Erythrocyte‐Inspired Delivery Systems
Hu, C. J., Fang, R. H., & Zhang, L. (2012) · Advanced Healthcare Materials · doi:10.1002/adhm.201200138 · Cited by 308
The alternative pathway of complement
Pangburn, M. K., & Müller-Eberhard, H. J. (1984) · Springer Seminars in Immunopathology · doi:10.1007/bf01893019 · Cited by 291
Complement Ligand-Receptor Interactions that Mediate Biological Responses
Fearon, D. T., & Wong, W. W. (1983) · Annual Review of Immunology · doi:10.1146/annurev.iy.01.040183.001331 · Cited by 290
Self-citationMacedo, A. C. L., & Isaac, L. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00055 · Cited by 290
Complement receptor is an inhibitor of the complement cascade.
Iida, K., & Nussenzweig, V (1981) · The Journal of experimental medicine · doi:10.1084/jem.153.5.1138 · Cited by 264
Membrane proteins that protect against complement lysis
Morgan, B. P., & Meri, S. (1994) · Springer Seminars in Immunopathology · doi:10.1007/bf01837366 · Cited by 263
Klickstein, L. B., Wong, W. W., Smith, J. A., Weis, J. H., Wilson, J. G., & Fearon, D. T. (1987) · The Journal of experimental medicine · doi:10.1084/jem.165.4.1095 · Cited by 261
Self-citationDamage to mammalian cells by proteins that form transmembrane pores
Bhakdi, S., & Tranum-Jensen, J. (2005) · Reviews of Physiology, Biochemistry and Pharmacology · doi:10.1007/bfb0027646 · Cited by 260
A role for complement receptor-like molecules in iron acquisition by Candida albicans
Moors, M. A., Stull, T. L., Blank, K. J., Buckley, H. R., & Mosser, D. M. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.6.1643 · Cited by 80
Metadata
- Authors
- Fearon, D. T.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1979-11
- Volume
- 76
- Issue
- 11
- Pages
- 5867-5871
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1997952082
- Cited by
- 440
- References
- 19
- FWCI
- 6.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.